American Association for Cancer Research
Browse
can-04-3049v2-supfig1.pdf (271.22 kB)

Supplementary Methods and Figure from Cellular Targets of Gefitinib

Download (271.22 kB)
journal contribution
posted on 2023-03-30, 12:08 authored by Dirk Brehmer, Zoltán Greff, Klaus Godl, Stephanie Blencke, Alexander Kurtenbach, Martina Weber, Stefan Müller, Bert Klebl, Matt Cotten, György Kéri, Josef Wissing, Henrik Daub
Supplementary Methods and Figure from Cellular Targets of Gefitinib

History

ARTICLE ABSTRACT

Targeted inhibition of protein kinases with small molecule drugs has evolved into a viable approach for anticancer therapy. However, the true selectivity of these therapeutic agents has remained unclear. Here, we used a proteomic method to profile the cellular targets of the clinical epidermal growth factor receptor kinase inhibitor gefitinib. Our data suggest alternative cellular modes of action for gefitinib and provide rationales for the development of related drugs.

Usage metrics

    Cancer Research

    Categories

    Keywords

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC